Polyoma virus specific T cells (National Institute of Neurological Disorders and Stroke)

多瘤病毒特异性T细胞

Report date: 2022/12/26 12:27:31

Base Information

Drug NamePolyoma virus specific T cells (National Institute of Neurological Disorders and Stroke)
Drug Alias NamePyVST
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLeukoencephalopathy, Progressive Multifocal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Neurological Disorders And Stroke
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Neurological Disorders And Stroke
Inactive CompaniesN/A
Active IndicationsLeukoencephalopathy, Progressive Multifocal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A